RF-Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Dermatology

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. Although most cases follow an indolent course, a subset of patients may develop locally advanced or metastatic disease. This review provides a comparative […]

The arrival of immunotherapy has revolutioned the management of patients with metastatic Merkel cell carcinoma (MCC). We conducted an observational, retrospective study of 14 cases treated with avelumab. The response rate was 57%: complete response […]

Immune checkpoint inhibitors (ICIs) have significantly advanced the treatment of cancer. They are not, however, free of adverse effects. These effects are called immune-related adverse events (irAEs) and often involve the skin. Most of the […]